Filing Details
- Accession Number:
- 0000899866-16-000367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-18 18:29:57
- Reporting Period:
- 2016-10-14
- Filing Date:
- 2016-10-18
- Accepted Time:
- 2016-10-18 18:29:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1633582 | Carsten Thiel | C/O Alexion Pharmaceuticals, Inc 100 College Street New Haven CT 06510 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Disposition | 2016-10-14 | 4,584 | $120.28 | 32,741 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.